Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lipoproteins – e.g. – egg yolk proteins – cylomicrons – etc.
Patent
1997-08-15
2000-07-18
Celsa, Bennett
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lipoproteins, e.g., egg yolk proteins, cylomicrons, etc.
530380, 514 21, A61K 3514, C07K 302
Patent
active
060909218
ABSTRACT:
The present invention relates to a process for purifying apolipoprotein A (ApoA) or apolipoprotein E (ApoE) from human plasma, by obtaining a fraction of human plasma containing said ApoA or ApoE, prepurifying said fraction in at least one step, binding said ApoA or ApoE to an anion-exchange chromatography gel, and thereafter eluting said ApoA or ApoE from said anion-exchange chromatography gel. The thus produced ApoA or ApoE can be used for the manufacture of a medicament in the treatment of atherosclerosis and cardiovascular diseases, or peripheral atherosclerosis and sepsis as well as in a method for treatment of atherosderosis and cardiovascular diseases, or peripheral atherosclerosis and sepsis when administered in a therapeutically effective amount.
REFERENCES:
patent: 4740304 (1988-04-01), Tjerneld et al.
patent: 5059528 (1991-10-01), Bollen et al.
patent: 5089602 (1992-02-01), Isliker et al.
patent: 5128318 (1992-07-01), Levine et al.
patent: 5834596 (1998-11-01), Ageland et al.
Kistler et al, "Large Scale Production of Human Plaxma Fractions," Vox Sang., 7:414-424 (1962).
Mezdour et al (1987), J. of Chromatography, vol. 414, pp. 35-45.
Rebenstein et al (1977), Can. J. Biochem, vol. 55, pp. 766-768.
Franceschini et al (1980), J. Clin Invest, vol. 66, pp. 892-900.
Weisgraber et al (1983), J. Biol. Chem, vol. 258, pp. 2508-2513.
Gualandri et al (1984), Am. J. Hum. Genet, vol. 37, pp. 1083-1097.
S.E. Ross et al (1985), Analytical Biochem, Rapid Chromatographic Purification of Apolipoproteins A-1 and A-II from Human Plasma, vol. 149, pp. 166-168.
Tricerri et al (1994), IJBC A Rapid and Efficient Procedure for the Purification of Human Apolipoprotein A-1 Using Gel-Filtration HPLC, vol. 1, pp. 159-166.
Peitsch et al (1989), Analytical Biochemistry, A Purification Method for Apolipoprotein A-I and A-II, vol. 178, pp. 301-305.
Lerch et al (1989), Protides Biol. Fluids, Isolation and Properties of Apolipoprotein A for Therapeutic Use, vol. 36, pp. 409-416.
Deeb et al (1991), J. Bio. Chem, vol. 266, pp. 13654-13660.
Takada et al (1991), J. Lipid Res, vol. 32, pp. 1275-1280.
Matsunaga et al (1991), Proc. Natl. Acad. Sci. USA vol. 88, lines 2793-2797.
Brewer et al (1978), Biochem. Biophys. Res. Commun, vol. 80, pp. 623-630.
NATO ASI Series Human Apolipoprotein Mutants III, ed. by C.R. Sirtori et al (1993), Springer Verlag, Berlin II vol. 73, pp. 81-96.
Cohn et al (1946), J. Am. Chem. Soc, vol. 68, pp. 459-475.
Oncley et al (1949), J. Am. Chem. Soc, vol. 71, pp. 541-550.
Index 11th Ed Merck & Co Inc Rabway NJ USA pp. 342 and 455 (1989).
Alred et al., "Application of temperature-induced phase partitioning at ambient temperature for enzyme purification," J Chromatogr A 659(2):289-98 (1994).
Alred et al., Synthesis of dye conjugates of ethylene oxide-propylene oxide copolymers and application in temperature-induced phase partitioning, Bioseparation 2(6):363-73 (1992).
Alred, et al., "Partitioning of ecdysteroids using temperature-induced phase separation," J. Chromatography 628: 205-214 (1993).
Anspach, et al., "Removal of endotoxins by affinity sorbents," J Chromatogr A 711(1):81-92 (1995).
Badimon, et al., "Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit," J Clin Invest 85(4):1234-41 (1990).
Berggren, et al., "Effects of salts and the surface hydrophobicity of proteins on partitioning in aqueous two-phase systems containing thermoseparating ethylene oxide-propylene oxide copolymers," J. Chromatography 718: 67-79 (1995).
Bradford, et al., "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding," Anal Biochem 72:248-54 (1976).
Calebrisi, et al., "Molecular characterization of native and recombinant apolipoprotein A-lMalano dimer. The introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I," J Biol Chem 269(51):32168-74 (1994).
Dorland's Illustrated Medical Dictionary (Twenty-fifth Edition) W.B. Saunders Publishers, 1974.
Eisenberg, et al., "A helical hydrophobic moment: a measure of the amphiphilicity of a helix," Nature 299: 371-374 (1982).
Emancipator, et al., "In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins," Infect Immun 60(2):596-601 (1992).
Fransechini, et al, "Apolipoprotein AlMilano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant," J Biol Chem 260(30):16321-5 (1985).
Fransechine, et al. "Apolipoprotein AlMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma," J Biol Chem 265(21):12224-31 (1990).
Fransechini, et al. "High density lipoprotein-3 heterogeneity in subjects with the apo-AlMilano variant," J Biol Chem 257(17): 9926-30 (1982).
Freudenberg, et al., "Natural Toxins," Proc. Inc. Symp. Anim., Plant Microb. Toxins, 6.sup.th ed. pp. 349-354.
Harris, et al. "Enzyme purification using temperature-induced phase formation," Bioseparation 2(4): 237-46 (1991).
Isaachi, et al., "Mature apolipoprotein Al and its precursor proApoAl: influence of the sequence at the 5' end of the gene on the efficiency of expression in Escherichia coli," Gene 81(1):129-37 (1989).
Johansson, et al., "Effects of Salts on the Partition of Proteins in Aqueous Polymeric Biphasic Systems," Acta Chimica Scandivica B 28: 873-882 (1974).
Karplus, et al., "A new method for reduction of endotoxin contamination from protein solutions," J Immunol Methods 105(2):211-20 (1987).
Matsumae, et al., "Specific removal of endotoxin from protein solutions by immobilized histidine," Biotechnol Appl Biochem 12(2):129-40 (1990).
Minobe, et al., "Characteristics and applications of adsorbents for pyrogen removal," Biotechnol Appl Biochem 10(2):143-53 (1988).
Moguilevsky, et al., "Production of human recombinant proapolipoprotein A-l in Escherichia coli: purification and biochemical characterization," DNA 8(6):429-36 (1989).
Munford, et al., "Binding of Salmonella typhimurium lipopolysacharides to rat high-density lipoproteins," Infect Immun 34(3):835-43 (1981).
Nilsson, et al., "Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors," EMBO J. 4(4):1075-80 (1985).
O'Brien, et al., "Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins," Circulation 98(6):519-27 (1998).
Pigiet, et al., "Thioredoxin-catalyzed refolding of disulfide-containing proteins," Proc Natl Acad Sci U S A. 83(20):7643-7 (1986).
Segrest, et al., "A molecular theory of lipid-protein interactions in the plasma lipoproteins," FEBS Lett. 38(3):247-58 (1974).
Sharma, et al., "Endotoxin detection and elimination in biotechnology," Biotechnol Appl Biochem 8(1):5-22 (1986).
Soma, et al., "Recombinant apolipoprotein A-lMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits," Circ Res. 76(3): 405-11 (1995).
Ulevitch, et al., "New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma," J Clin Invest 67(3):827-37 (1981).
Walter, et al., Partioning procedures and techniques: cells, organelles, and membranes, Methods Enzymol 228:42-63 (1994).
Weisgraber, et al. "Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity," J Biol Chem 266(18):12029-34 (1991).
Gualandri et al (1985), Am. J. Hum. Genet., vol. 37, pp. 1083-1097.
Wiklund Sara
Winge Stefan
Celsa Bennett
Esperion Therapeutics, Inc.
LandOfFree
Process for purifying apolipoprotein a or apolipoprotein e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for purifying apolipoprotein a or apolipoprotein e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for purifying apolipoprotein a or apolipoprotein e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038044